These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32997359)
21. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors. Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184 [TBL] [Abstract][Full Text] [Related]
22. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands]. Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264 [TBL] [Abstract][Full Text] [Related]
23. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Su ZF; He J; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2003 Feb; 30(2):141-9. PubMed ID: 12623113 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules. Ji S; Zhou Y; Shao G; Liu S Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129 [TBL] [Abstract][Full Text] [Related]
25. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166 [TBL] [Abstract][Full Text] [Related]
33. 99mTc-Labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation. Liu S; Harris AR; Williams NE; Edwards DS Bioconjug Chem; 2002; 13(4):881-6. PubMed ID: 12121145 [TBL] [Abstract][Full Text] [Related]
34. Phosphine-containing HYNIC derivatives as potential bifunctional chelators for (99m)Tc-labeling of small biomolecules. Purohit A; Liu S; Casebier D; Edwards DS Bioconjug Chem; 2003; 14(4):720-7. PubMed ID: 12862424 [TBL] [Abstract][Full Text] [Related]
35. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates. Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353 [TBL] [Abstract][Full Text] [Related]
36. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide. Decristoforo C; Mather SJ Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875 [TBL] [Abstract][Full Text] [Related]
37. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc. Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277 [TBL] [Abstract][Full Text] [Related]
38. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation. De K; Banerjee I; Misra M Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164 [TBL] [Abstract][Full Text] [Related]